Nathan Forbush
Pediatrics · Layton, UTNPI 1962439851
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,097 of the $2,909 with a category attached, or 72.1%. 21 manufacturers reported payments, led by Seqirus USA Inc at 38.5% of the total. Reporting peaked in 2019 at $1,420 and has fallen 88.9% since, to $158 in 2025. Among pediatrics clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 107 payments — averaging $27.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seqirus USA Inc$1K
- Supernus Pharmaceuticals, Inc.$357
- Pfizer$320
- Ironshore Pharmaceuticals Inc.$203
- Tris Pharma Inc$169
- Merck$116
- plus $625 from 15 others
Across 272 payments — averaging $13,117 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$3M
- Seqirus USA Inc$217K
- Sanofi Pasteur Inc.$171K
- AstraZeneca$83K
- Incyte Corporation$74K
- Astrazeneca UK Limited$34K
- plus $33K from 1 others
What the payments were for
- Travel & lodging$81228%
- Food & beverage$2,09772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seqirus USA Inc | 8 | $1,120 |
| Supernus Pharmaceuticals, Inc. | 7 | $357 |
| Pfizer | 29 | $320 |
| Ironshore Pharmaceuticals Inc. | 11 | $203 |
| Tris Pharma Inc | 10 | $169 |
| Merck | 6 | $116 |
| Cranial Technologies, Inc | 5 | $94 |
| GSK | 5 | $80 |
| Neurelis, Inc. | 5 | $75 |
| Sanofi Pasteur Inc. | 3 | $59 |
| Sobi, Inc | 3 | $55 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Adlon Therapeutics L.p. | 2 | $33 |
| Shire North American Group Inc | 2 | $30 |
| AstraZeneca | 1 | $26 |
| Phadia US Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Corium, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,909 in reported general payments places this provider in the 90th percentile of 439 pediatrics providers in Utah.
Other pediatrics in Layton
- Mari LuceLayton$289K
- Michael HussemanLayton$4K
- Noel NyeLayton$3K
- Ryan EvansLayton$3K
- Brent EberhardLayton$2K
- Jason HoaglandLayton$2K
- Bryan EllertsonLayton$2K
- Robert HokiLayton$2K
- Colton RagsdaleLayton$2K
- David NuttallAmerican Fork$307K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.